首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Innate immunity and cardiomyocytes in ischemic heart disease
Authors:Li Lin  Anne A Knowlton
Institution:1. Department of Physiology, Second Military Medical University, Shanghai 200433, China;2. Molecular and Cellular Cardiology, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA;3. Department of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA;4. Department of Pharmacology, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA;5. The Northern California VA, Sacramento, CA, USA
Abstract:Myocardial ischemia/reperfusion (I/R) is the most common cause of myocardial inflammation, which is primarily a manifestation of the innate immune responses. Innate immunity is activated when pattern recognition receptors (PRRs) respond to molecular patterns common to microbes and to danger signals expressed by injured or infected cells, so called pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). The expression of various PRRs in cardiomyocytes and the release of DAMPs from cardiomyocytes subjected to I/R injury, through active mechanisms as well as passive processes, enable cardiomyocytes to generate innate immune responses. Studies in isolated heart and cardiomyocytes have confirmed the inflammatory and functional effects of cardiac PRRs especially Toll-like receptors in response to I/R-derived DAMPs, such as heat shock proteins. This review addresses the active role of cardiomyocytes in mediating innate inflammatory responses to myocardial I/R. We propose that cardiomyocytes act as innate immune cells in myocardial I/R injury.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号